Alpha-1 adrenoceptors mediate splanchnic nerve inhibition of pentagastrin-induced gastric acid secretion and mucosal blood flow in rats.
Effects of stimulation of the sympathetic nervous system on pentagastrin-induced increases in gastric acid secretion and mucosal blood flow (MBF) were studied in anesthetized, gastric fistula rats. Gastric acid secretion and MBF were increased by i.v. infusion of a submaximal dose of pentagastrin (1.0 microgram/kg/min). Stimulation of the splanchnic nerve was carried out under the steady, increased state of pentagastrin-stimulated acid secretion and MBF. Stimulation of the splanchnic nerve significantly reduced gastric acid secretion, while MBF was little affected. Thus, the delta MBF/delta H+ ratio was significantly increased during this stimulation. Phentolamine, but not propranolol, abolished the inhibitory effects of splanchnic nerve stimulation on the pentagastrin-stimulated gastric acid secretion. In addition, prazosin, but not yohimbine, abolished the inhibitory effects of splanchnic nerve stimulation on the pentagastrin-induced gastric acid secretion. These results suggest that splanchnic nerves directly inhibit pentagastrin-induced gastric acid secretion through alpha-1 adrenoceptors, independently of changes in the MBF, in rats.
D000818:Animals; D004558:Electric Stimulation; D005744:Gastric Acid / Q000378:metabolism*; D005745:Gastric Acidity Determination; D005753:Gastric Mucosa / Q000098:blood supply*; D008297:Male; D010418:Pentagastrin / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology; D011224:Prazosin / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011942:Receptors, Adrenergic, alpha / Q000502:physiology*; D013153:Splanchnic Nerves / Q000502:physiology*; D015016:Yohimbine / Q000494:pharmacology
D011942:Receptors, Adrenergic, alpha; D015016:Yohimbine; D011433:Propranolol; D010418:Pentagastrin; D011224:Prazosin; D010646:Phentolamine